Levmetamfetamine is technically a sympathomimetic drug, meaning it activates part of the nervous system, but it is not a meaningful central nervous system stimulant. Despite being a mirror-image form of methamphetamine, its stimulant effects are roughly 10 times weaker than those of d-methamphetamine (the potent, illicit form), and at the doses found in over-the-counter nasal inhalers, it produces virtually no psychoactive stimulation.
Why the Name Sounds Alarming
Methamphetamine exists as two mirror-image molecules called enantiomers, the same way your left and right hands are mirror images of each other. The “d” form (dextromethamphetamine) is the version responsible for the powerful stimulant and euphoric effects associated with illicit methamphetamine. The “l” form (levmetamfetamine) is the other hand of the molecule. Although the two share the same chemical formula, their three-dimensional shapes are different, and that difference dramatically changes how each one interacts with your brain.
Levmetamfetamine primarily triggers the release of norepinephrine, a chemical that narrows blood vessels. That’s why it works as a nasal decongestant: it shrinks swollen tissue in your nasal passages. Its effect on dopamine, the brain chemical most responsible for the “high” of stimulant drugs, is far weaker. Research on rat brain tissue found that d-methamphetamine is approximately 17 times more potent at releasing dopamine and 42 times more potent at blocking its reuptake compared to levmetamfetamine.
How It Affects the Body in Practice
Clinical pharmacology studies paint a clear picture: inhaled levmetamfetamine at over-the-counter doses does not raise blood pressure or heart rate the way d-methamphetamine does. In fact, researchers found that it may slightly depress cardiac function, producing small declines in stroke volume and cardiac output. That’s essentially the opposite of what a classical stimulant does to the cardiovascular system.
Subjective effects were similarly minimal. In controlled studies, participants reported noticing “some drug effect” after using the inhaler, but when asked to rate how good the effect felt on a 0 to 100 scale, the average peak rating was only 9.7, even at doses far exceeding normal use (64 inhalations in a session, compared to the recommended 2 per nostril). In practical terms, you might notice a mild sensation from the inhaler, but it does not produce euphoria, alertness, or the wakefulness associated with stimulant drugs.
Where You’ll Find It
Levmetamfetamine is the active ingredient in Vicks VapoInhaler and its generic equivalents, sold over the counter in the United States as nasal decongestant inhalers. Each inhaler contains 50 mg of levmetamfetamine and delivers between 0.04 and 0.150 mg per 800 mL of inhaled air. The recommended dose is two inhalations per nostril, and the product should not be used for more than seven days to avoid rebound congestion.
The product carries no DEA scheduling. It is sold without a prescription and without the behind-the-counter restrictions that apply to pseudoephedrine, another common decongestant. This regulatory treatment reflects the consensus that levmetamfetamine has negligible abuse potential at its approved doses.
Drug Testing Complications
One real-world concern with levmetamfetamine is that it can trigger a positive result on a standard urine drug screen for amphetamines. The initial screening tests used by most labs cannot tell the two mirror-image forms apart. A study published in the Journal of Analytical Toxicology found that one widely used screening test (EMIT II Plus) produced false-positive results in about 2.2% of urine samples from people who had used only a Vicks VapoInhaler.
The good news is that more advanced confirmatory testing can distinguish the two forms completely. When researchers used a specialized method that separates the left-handed and right-handed molecules, no d-methamphetamine or d-amphetamine was detected in any urine specimen from inhaler users. If you use a levmetamfetamine inhaler and face a positive drug screen, a medical review officer can request this isomer-specific analysis to confirm the result came from a legal decongestant rather than illicit methamphetamine. The catch is that standard confirmatory methods don’t automatically perform this separation, so you may need to specifically request it or disclose your inhaler use.
Stimulant in Name, Not in Effect
Levmetamfetamine does cross into the brain, and it does interact with some of the same receptors that classical stimulants target. In a strict pharmacological sense, it has weak stimulant properties. But “weak” here means roughly one-tenth the potency of d-methamphetamine for producing any psychomotor stimulation in animal studies, and in humans at normal inhaler doses, the cardiovascular and subjective effects are close to zero. For all practical purposes, using a levmetamfetamine nasal inhaler as directed will decongest your nose without producing stimulant effects you would notice.